Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes

AIMS: Doxorubicin (DOX) is among the most effective chemotherapies used in paediatric cancer patients. However, the clinical utility of DOX is offset by its well-known cardiotoxicity, which often does not appear until later in life. Since hypertension significantly increases the risk of late-onset h...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Cardiovasc Res
Main Authors: Matsumura, Nobutoshi, Zordoky, Beshay N, Robertson, Ian M, Hamza, Shereen M, Parajuli, Nirmal, Soltys, Carrie-Lynn M, Beker, Donna L, Grant, Marianne K, Razzoli, Maria, Bartolomucci, Alessandro, Dyck, Jason R B
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2018
Fag:
Original Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6054166/
https://ncbi.nlm.nih.gov/pubmed/29566148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cvr/cvy064
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker